AUPO269996A0 - A method of prophylaxis and treatment - Google Patents

A method of prophylaxis and treatment

Info

Publication number
AUPO269996A0
AUPO269996A0 AUPO2699A AUPO269996A AUPO269996A0 AU PO269996 A0 AUPO269996 A0 AU PO269996A0 AU PO2699 A AUPO2699 A AU PO2699A AU PO269996 A AUPO269996 A AU PO269996A AU PO269996 A0 AUPO269996 A0 AU PO269996A0
Authority
AU
Australia
Prior art keywords
prophylaxis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO2699A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Priority to AUPO2699A priority Critical patent/AUPO269996A0/en
Publication of AUPO269996A0 publication Critical patent/AUPO269996A0/en
Priority to CA002267063A priority patent/CA2267063A1/en
Priority to JP10516048A priority patent/JP2001502306A/en
Priority to PCT/AU1997/000654 priority patent/WO1998014203A1/en
Priority to AU43718/97A priority patent/AU4371897A/en
Priority to US10/867,149 priority patent/US20050025758A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AUPO2699A 1996-10-01 1996-10-01 A method of prophylaxis and treatment Abandoned AUPO269996A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPO2699A AUPO269996A0 (en) 1996-10-01 1996-10-01 A method of prophylaxis and treatment
CA002267063A CA2267063A1 (en) 1996-10-01 1997-10-01 A method and compositions for treatment of insulin-dependant diabetes mellitus
JP10516048A JP2001502306A (en) 1996-10-01 1997-10-01 Methods and compositions for treating insulin-dependent diabetes
PCT/AU1997/000654 WO1998014203A1 (en) 1996-10-01 1997-10-01 A method and compositions for treatment of insulin-dependant diabetes mellitus
AU43718/97A AU4371897A (en) 1996-10-01 1997-10-01 A method and compositions for treatment of insulin-dependant diabetes mellitus
US10/867,149 US20050025758A1 (en) 1996-10-01 2004-06-14 Method and compositions for treatment of insulin-dependant diabetes mellitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO2699A AUPO269996A0 (en) 1996-10-01 1996-10-01 A method of prophylaxis and treatment

Publications (1)

Publication Number Publication Date
AUPO269996A0 true AUPO269996A0 (en) 1996-10-24

Family

ID=3797010

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO2699A Abandoned AUPO269996A0 (en) 1996-10-01 1996-10-01 A method of prophylaxis and treatment

Country Status (4)

Country Link
JP (1) JP2001502306A (en)
AU (1) AUPO269996A0 (en)
CA (1) CA2267063A1 (en)
WO (1) WO1998014203A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098645A1 (en) * 2003-05-12 2004-11-18 Tolerogen, Ltd. Immunoglobulin conjugates of autoantigens and their use in the prevention of disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654324A (en) * 1981-08-27 1987-03-31 Eli Lilly And Company Human proinsulin pharmaceutical formulations
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
DK119785D0 (en) * 1985-03-15 1985-03-15 Nordisk Gentofte INSULIN PREPARATION
BR9007950A (en) * 1989-12-20 1992-10-27 Brigham & Womens Hospital METHOD FOR TREATING OR PREVENTING THE MANIFESTATION OF AN AUTO-IMMUNE DISEASE IN A MAMMAL, PHARMACEUTICAL FORMULATION, METHOD FOR TREATING AN AUTO-IMMUNE DISEASE, AND METHOD FOR TREATING A MAMMAL WITH ACCIDENT OF AUTO-IMMUNE DISEASE
CA2015515C (en) * 1990-01-03 1999-12-07 Jean-Marie Saint-Remy Pharmaceutical compositions containing antigen-antibody complexes and uses therefor
KR100419037B1 (en) * 1994-03-07 2004-06-12 넥타르 테라퓨틱스 Methods of delivery of insulin through the lungs and their composition
AU3094795A (en) * 1994-07-08 1996-02-09 Trustees Of Dartmouth College Proinsulin peptide compounds for detecting and treating type i diabetes

Also Published As

Publication number Publication date
CA2267063A1 (en) 1998-04-09
WO1998014203A1 (en) 1998-04-09
JP2001502306A (en) 2001-02-20

Similar Documents

Publication Publication Date Title
AUPN271295A0 (en) Method of treatment
GB9617780D0 (en) Method of treatment
AU7650396A (en) Treatment and prophylaxis of osteoporosis
AUPO359396A0 (en) A method of treatment and pharmaceutical compositions useful for same
AU7871498A (en) A method of treating hypercholesterolemia and related disorders
AU2548595A (en) Auto-tuning controller and method of use therefor
AU6973294A (en) Method for treatment of a piece
AU4027097A (en) Method of treatment
AUPO439396A0 (en) A method of treatment and prophylaxis
AU3861595A (en) A screw and method for the manufacturing and treatment of a screw
ZA973988B (en) Method of treatment
AUPO269996A0 (en) A method of prophylaxis and treatment
AUPO391296A0 (en) A method of prophylaxis and treatment
AU7871598A (en) A method of treatment and prophylaxis
AUPP776298A0 (en) A method of treatment and prophylaxis
AUPP068297A0 (en) A method of prophylaxis and treatment
AUPM836794A0 (en) Improved method and composition for the treatment of ulcers
AUPP748898A0 (en) A method of prophylaxis and treatment
AU1093797A (en) A method of treating hypercholesterolemia and related disorders
AUPO220696A0 (en) A method of treatment and agents useful for same
AUPO269896A0 (en) A method of treatment
AUPQ362799A0 (en) A method of prophylaxis and treatment
AUPQ022099A0 (en) A method of prophylaxis and treatment
AUPP937799A0 (en) A method of prophylaxis and treatment
AUPO438796A0 (en) Method of treatment